Exploring the Effect of Combined Chinese and Western Treatment on Home Medical Care

July 24, 2018 updated by: Taipei City Hospital

Effectiveness of Combining Antihypertensive Drugs and Acupuncture on Isolated Systolic Hypertension of Elderly Patients at Home

combine antihypertensive drugs and acupuncture to isolated systolic hypertension elderly patients at home

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The investigators would like to compare the effectiveness of acupuncture and drug therapy on blood pressure.

The investigators chose acupuncture point according the Traditional Chinese Medicine theory, besides, each patient was using 1-3 antihypertensive drug of a heterogeneous pharmacological group ranging from angiotensin-converting enzyme inhibitor (ACE inhibitor), diuretics, and beta blockers.

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 104
        • Taipei City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. patient with isolated blood pressure diagnosis by physicians and BP >140/<90 mmHg
  2. patient took the drug to control blood pressure for more than one year
  3. age>65 years old
  4. Willing to participate in this study

Exclusion Criteria:

  1. Suspected acute stroke
  2. chest pain or dyspnea
  3. ingestion of short-acting antihypertensive medication within 2 h prior to the beginning of the study
  4. body temperature >37.5∘C(99.5∘F)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: drug use
routine drug use, each patient was using 1-3 antihypertensive drug of a heterogeneous pharmacological group ranging from ACE inhibitors, diuretics, and beta blockers
Experimental: drug combine acupuncture
routine drug use combine acupuncture twice a week for 3 months
antihypertension drug, acupuncture twice a week for 3 months
Other Names:
  • drug

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood pressure
Time Frame: change from Baseline Systolic Blood Pressure at 3 months
measure blood pressure after the treatment compare the initial blood pressure
change from Baseline Systolic Blood Pressure at 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Traditional Chinese Medicine constitution
Time Frame: use the questionnaire at Baseline, 1.5 month, and three month later
use The Constitution in Chinese Medicine Questionnaire
use the questionnaire at Baseline, 1.5 month, and three month later
heart rate variability
Time Frame: use ANS watch to monitor patient's condition at Baseline, 1.5 month, and three month later
use autonomic nervous system (ANS) watch to monitor patient's heart rate variability, Low Frequency/High Frequency ratio
use ANS watch to monitor patient's condition at Baseline, 1.5 month, and three month later

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Kuei-Yu Huang, Taipei City Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2018

Primary Completion (Anticipated)

September 1, 2018

Study Completion (Anticipated)

May 31, 2019

Study Registration Dates

First Submitted

June 25, 2018

First Submitted That Met QC Criteria

July 24, 2018

First Posted (Actual)

July 26, 2018

Study Record Updates

Last Update Posted (Actual)

July 26, 2018

Last Update Submitted That Met QC Criteria

July 24, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TCHIRB-10703120-E

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on acupuncture

3
Subscribe